Patrick Heron

Patrick Heron

Direktör/Styrelseledamot på ARCUTIS BIOTHERAPEUTICS, INC.

Förmögenhet: 2 M $ per 2026-06-30

55 år
Health Technology
Commercial Services
Finance

Profil

Mr. Patrick J.
Heron
is a Lead Independent Director at MBX Biosciences, Inc., an Independent Director at Mirum Pharmaceuticals, Inc., an Independent Director at Arcutis Biotherapeutics, Inc. and a Managing Partner at Frazier Management LLC.
He is on the Board of Directors at MBX Biosciences, Inc., Mirum Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., Alpha-9 Oncology, Inc., Bluewater Biosciences, Inc., Iterum Therapeutics International Ltd., Iterum Therapeutics US Holding Ltd., VentiRx Pharmaceuticals, Inc., Zavante Therapeutics, Inc. and Calibrium LLC.
Mr. Heron was previously employed as an Independent Director by HilleVax, Inc., an Independent Non-Executive Director by Passage Bio, Inc., a Chairman by Scout Bio, Inc., an Independent Director by Vaxcyte, Inc., an Independent Director by Iterum Therapeutics Plc, an Independent Director by Tobira Therapeutics, Inc., an Independent Director by Imago BioSciences, Inc., an Independent Director by Cidara Therapeutics, Inc., an Independent Director by Collegium Pharmaceutical, Inc., an Independent Director by Tobira Therapeutics, Inc. /Old/, an Engagement Manager by McKinsey & Co., Inc., a Principal by Cetus Corp., a Chairman by Kalidex Pharmaceuticals, Inc., and a Principal by The General Hospital Corp.
He also served on the board at SanReno Therapeutics, Silvergate Pharmaceuticals, Inc., Calixa Therapeutics, Inc., Marcadia Biotech, Inc., Cerexa, Inc., Trubion Pharmaceuticals, Inc., MedPointe, Inc., QuatRx Pharmaceuticals Co., Amunix, Inc., ARMO Biosciences, Inc., Avera Pharmaceuticals, Inc., Chimerix, Inc., Ignyta, Inc., Informed Medical Communications, Inc., Moximed, Inc., Panomics LLC, PreCision Dermatology, Inc. and Recida Therapeutics, Inc. He received his undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from Harvard Business School.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-06-05 32 213 ( 0,03 % ) 844 625 $ 2026-06-30
2026-06-15 5 703 ( 0,01 % ) 667 650 $ 2026-06-30
0,03 %
2025-01-31 9 110 ( 0,03 % ) 614 925 $ 2026-06-30
0,02 %
2025-11-01 14 937 ( 0,02 % ) 162 066 $ 2026-06-30
2026-06-04 0 ( -.--% ) - $ 2026-06-30

Aktiva positioner av Patrick Heron

FöretagPositionStart
ARCUTIS BIOTHERAPEUTICS, INC. Direktör/Styrelseledamot -
MIRUM PHARMACEUTICALS, INC. Direktör/Styrelseledamot 2018-11-07
MBX BIOSCIENCES, INC. Direktör/Styrelseledamot 2020-07-01
Privat kapitalinvesterare 1999-08-01
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ -

Tidigare kända positioner av Patrick Heron

FöretagPositionSlut
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Se detaljerna i Patrick Herons erfarenhet

Patrick Herons utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

75

Första gradens relationer

45

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag45

Finance

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Börsen
  2. Insiders
  3. Patrick Heron